James F. Oliviero III, CEO, President and Director at Checkpoint Therapeutics, Inc. (CKPT), sold 10,261 shares at $4.77 ($49K) on 2023-02-01, disclosed to the SEC on 2023-02-03.
Seasonal sale ($49k) by CEO, President and Director — this insider has traded CKPT in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CKPT | SELL | 2024-12-20 | $6.1M | — | Filing → |
| CKPT | SELL | 2024-06-28 | $101K | — | Filing → |
| CKPT | SELL | 2024-03-01 | $12K | — | Filing → |